Dishman Carbogen Amcis Limited (DCAL.NS)
INR 193.06
(-0.01%)
INR 193.06
(-0.01%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 95.81 Billion INR | 1.35% |
| 2022 | 94.53 Billion INR | 9.45% |
| 2021 | 86.37 Billion INR | 3.76% |
| 2020 | 83.24 Billion INR | 1.24% |
| 2019 | 82.22 Billion INR | 12.2% |
| 2018 | 73.28 Billion INR | 2.12% |
| 2017 | 71.76 Billion INR | 8.84% |
| 2016 | 65.93 Billion INR | 121.22% |
| 2015 | 29.8 Billion INR | 6.11% |
| 2014 | 28.08 Billion INR | 9.97% |
| 2013 | 25.54 Billion INR | 11.48% |
| 2012 | 22.91 Billion INR | 1.44% |
| 2011 | 22.58 Billion INR | 8.47% |
| 2010 | 20.82 Billion INR | 16.18% |
| 2009 | 17.92 Billion INR | 6.11% |
| 2008 | 16.89 Billion INR | 13.09% |
| 2007 | 14.93 Billion INR | 28.66% |
| 2006 | 11.6 Billion INR | 94.91% |
| 2005 | 5.95 Billion INR | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | - INR | -100.0% |
| 2023 FY | 95.81 Billion INR | 1.35% |
| 2023 Q1 | - INR | -100.0% |
| 2023 Q3 | - INR | -100.0% |
| 2023 Q4 | 95.81 Billion INR | 0.0% |
| 2023 Q2 | 95.01 Billion INR | 0.0% |
| 2022 Q3 | - INR | -100.0% |
| 2022 Q4 | 94.53 Billion INR | 0.0% |
| 2022 FY | 94.53 Billion INR | 9.45% |
| 2022 Q1 | - INR | -100.0% |
| 2022 Q2 | 88.26 Billion INR | 0.0% |
| 2021 Q1 | - INR | -100.0% |
| 2021 Q4 | 86.37 Billion INR | 0.0% |
| 2021 Q2 | 85.35 Billion INR | 0.0% |
| 2021 FY | 86.37 Billion INR | 3.76% |
| 2020 Q4 | 83.24 Billion INR | 0.0% |
| 2020 Q2 | 82.15 Billion INR | 0.0% |
| 2020 FY | 83.24 Billion INR | 1.24% |
| 2020 Q1 | - INR | -100.0% |
| 2020 Q3 | - INR | -100.0% |
| 2019 FY | 82.22 Billion INR | 12.2% |
| 2019 Q4 | 82.22 Billion INR | 0.0% |
| 2019 Q2 | 77.74 Billion INR | 0.0% |
| 2019 Q1 | - INR | -100.0% |
| 2019 Q3 | - INR | -100.0% |
| 2018 Q4 | 73.28 Billion INR | 0.0% |
| 2018 FY | 73.28 Billion INR | 2.12% |
| 2018 Q3 | - INR | -100.0% |
| 2018 Q2 | 76.31 Billion INR | 0.0% |
| 2018 Q1 | - INR | -100.0% |
| 2017 FY | 71.76 Billion INR | 8.84% |
| 2017 Q1 | - INR | -100.0% |
| 2017 Q2 | 67.25 Billion INR | 0.0% |
| 2017 Q3 | - INR | -100.0% |
| 2017 Q4 | 71.76 Billion INR | 0.0% |
| 2016 Q2 | 30.86 Billion INR | 0.0% |
| 2016 FY | 65.93 Billion INR | 121.22% |
| 2016 Q4 | 65.93 Billion INR | 0.0% |
| 2015 Q4 | 29.8 Billion INR | 0.0% |
| 2015 FY | 29.8 Billion INR | 6.11% |
| 2015 Q2 | 28.41 Billion INR | 0.0% |
| 2014 Q2 | 26.4 Billion INR | 0.0% |
| 2014 FY | 28.08 Billion INR | 9.97% |
| 2014 Q4 | 28.08 Billion INR | 0.0% |
| 2013 Q2 | 25.42 Billion INR | 0.0% |
| 2013 Q4 | 25.54 Billion INR | 0.0% |
| 2013 FY | 25.54 Billion INR | 11.48% |
| 2012 Q4 | 22.91 Billion INR | 0.0% |
| 2012 FY | 22.91 Billion INR | 1.44% |
| 2011 FY | 22.58 Billion INR | 8.47% |
| 2011 Q4 | 22.58 Billion INR | 0.0% |
| 2010 FY | 20.82 Billion INR | 16.18% |
| 2009 FY | 17.92 Billion INR | 6.11% |
| 2008 FY | 16.89 Billion INR | 13.09% |
| 2007 FY | 14.93 Billion INR | 28.66% |
| 2006 FY | 11.6 Billion INR | 94.91% |
| 2005 FY | 5.95 Billion INR | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Biocon Limited | 560.7 Billion INR | 82.912% |
| Blue Jet Healthcare Limited | 10.58 Billion INR | -804.891% |
| Concord Biotech Limited | 17 Billion INR | -463.378% |
| Jubilant Ingrevia Limited | 47.31 Billion INR | -102.486% |
| Lyka Labs Limited | 1.56 Billion INR | -6013.545% |
| Panacea Biotec Limited | 12.4 Billion INR | -672.271% |
| Piramal Pharma Limited | 153.11 Billion INR | 37.425% |
| SMS Lifesciences India Limited | 3.9 Billion INR | -2353.505% |
| Supriya Lifescience Limited | 9.21 Billion INR | -940.058% |
| Syngene International Limited | 61.51 Billion INR | -55.755% |
| TAKE Solutions Limited | 881.05 Million INR | -10774.99% |
| Zota Health Care Limited | 2.28 Billion INR | -4096.327% |